ISB News

‘GEN’ Highlights ISB Symposium

In a feature article in “Genetic Engineering & Biotechnology News,” writer Kathy Liszewski takes readers through the minds of systems biologists whom she compares to experts in biological cryptanalysis who are hunting for the “subcellular double agents and moles” behaving nefariously and causing disease. The writer shares some key points from speakers who presented at ISB’s annual Symposium, including ISB assistant professor Dr. Naeha Subramanian and Dr. Trevor Mundel, of the Gates Foundation. The Symposium took place on April 3-4. READ ARTICLE

Recent Articles

  • Timing is Everything: ISB Study Finds Link Between Bowel Movement Frequency and Overall Health

    Everybody poops, but not every day. An ISB-led research team examined the clinical, lifestyle, and multi-omic data of more than 1,400 healthy adults. How often people poop, they found, can have a large influence on one’s physiology and health.

  • Wei Wei, PhD

    Dr. Wei Wei Promoted to Associate Professor

    Wei Wei, PhD – an accomplished cancer researcher with expertise in biotechnology and cancer systems biology – has been promoted to ISB associate professor. The Wei Lab focuses on understanding how cancer cells adapt to therapeutic treatment to foster therapy resistance by coordinating their internal molecular machinery and how these adaptive changes evolve within diverse tumors influenced by the tumor microenvironment. 

  • Drs. Nitin Baliga and James Park

    How Glioblastoma Resists Treatment – and Ways to Prevent It

    Glioblastoma is one of the deadliest and most aggressive forms of primary brain cancer in adults and is known for its ability to resist treatment and to recur. ISB researchers have made breakthrough discoveries in understanding the mechanisms behind acquired resistance, focusing on a rare and stubborn group of cells within tumors called glioma stem-like cells.